Royal Dutch Pharmacists Association

Recent papers from Royal Dutch Pharmacists Association

1. Quality indicators measuring pharmaceutical care for asthma and chronic obstructive pulmonary disease within primary care: a scoping reviewAmerican Journal of Health-System Pharmacy · 2026
2. Supporting clinical guidelines for opioid conversion to methadone and tapering to prevent withdrawal in critically ill children using physiology based pharmacokinetic modeling and simulationPLoS ONE · 2026
3. Caspase-3 regulates RNA splicing and mitochondrial dynamics in microglia during Parkinson’s diseaseCell Death and Disease · 2026
4. Clinical Documentation as Clinical Practice: Beyond the Novel Risks of AI Summarization ToolsThe American Journal of Bioethics · 2026
5. The Development of the European Sleep Questionnaire A New Patient‐Reported Outcome MeasureJournal of Sleep Research · 2026
6. Rating Down for Publication Bias is Rare in Cochrane Reviews: A Descriptive StudyCochrane Evidence Synthesis and Methods · 2026
7. Development and Updating of Clinical Practice Guidelines—The Necessity of International CollaborationClinical and Public Health Guidelines · 2026
8. Integrating Planetary Health in Health Guidelines (GRADE Guidance 46)Annals of Internal Medicine · 2026
9. Guidelines or Other Guidance Documents for Rare Diseases in the Netherlands: When and Where to Invest (Effort, Time and Money)?Clinical and Public Health Guidelines · 2026
10. Planetary Health in Health Guidelines: Expert Workshop Report 2024Clinical and Public Health Guidelines · 2026
11. Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapyBritish Journal of Clinical Pharmacology · 2026
12. Do the redefined EUCAST susceptibility categories warrant adjustment of paediatric antibiotic dosages? Pragmatic physiologically based pharmacokinetic modelling of four commonly used agentsJournal of Antimicrobial Chemotherapy · 2026
13. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and CYP2C19 and tricyclic antidepressantsEuropean Journal of Human Genetics · 2026
14. Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE studyEClinicalMedicine · 2025
15. Reflections on the future of child & adolescent mental healthInternational Review of Psychiatry · 2025
16. A qualitative study among guideline developers revealed challenges and strategies for rare disease guideline developmentJournal of Clinical Epidemiology · 2025
17. Assessing effects of nature-based and other municipal adaptation measures on insured heavy rain damagesNatural hazards and earth system sciences · 2025
18. Unused medication: mapping the impact across the Dutch healthcare systemThe Journal of Climate Change and Health · 2025
19. Extemporaneous Compounding, Pharmacy Preparations and Related Product Care in the NetherlandsPharmaceutics · 2025
20. Environmentally friendly inhaler decision-making with personalized care in asthma and chronic obstructive pulmonary disease: a qualitative studyExploratory Research in Clinical and Social Pharmacy · 2025